Open Closing in a 9 months
Unlicensed and Specials Medicines
Descriptions
Health and Social Care Trusts (HSC) in Northern Ireland plan to tender for Unlicensed Medicines and Specials later this year. In order to assist with the development of a service specification and an appropriate methodology for the assessment of tenders, we are keen to engage with suppliers who would be willing to provide unlicensed and, or specials medicines to Health Trusts in Northern Ireland. The purpose of the engagement is to aid our understanding of current market conditions and capacity. The HSC intend to establish a multi-supplier framework which will cater for four categories of medicines: 1. Aseptically prepared unlicensed medicines, 2. Imported specials, 3. Non-aseptic specials, 4. Over-labelled medicines. We hope that the Preliminary Market Engagement (PME) will help encourage supplier interest in this tender. It will also help us understand any barriers to tendering that suppliers currently face so these can be considered when drafting the HSC tender.
Timeline
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
North West
South West
North East
East of England
Yorkshire and The Humber
South East
East Midlands
West Midlands
Ireland
Wales
Scotland
Northern Ireland
London
CPV Codes
85149000 - Pharmacy services
33600000 - Pharmaceutical products
Keywords
medicinal drugs
prescription medicines
generic pharmaceuticals
active pharmaceutical ingredients
pharmaceutical compounds
hospital pharmacy
clinical pharmacy
inpatient medication dispensing
sterile compound preparation
pharmacological management
medication safety services
pharmaceutical stock management
IV admixture
formulary services
hospital drug distribution
Tender Lot Details
2 Tender Lots
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors
